Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 360 of 2459…289 Figure 1Recanalization rate by occlusion location following tenecteplase administration. Spontaneous recanalization occurred more freque…
…d hemorrhagic transformation after intravenous thrombolysis for acute ischemic stroke in this single-center retrospective study. These findings suppo…
…; NIHSS: NIH Stroke Scale; BNP: Brain Natriuretic Peptide; GCS: Glasgow Coma Scale…
… can increase the risk of vessel injury or distal embolization. Intra-arterial thrombolysis has emerged as a potential primary endovascular strategy; howev…
…autism and repeated long-discredited claims linking vaccines to autism.2…
…Background Australian guidelines recommend the CHA 2DS2-VA (congestive heart failure, hypertension, age ≥75 years (double weight), diabetes mellitus…
… an overall coordinated approach for the management of CYP with hypertonia, with individual studies instead focussing on either specific s…
…ighlighting the need for safer non-opioid treatment strategies. Metformin is a widely prescribed oral antihyperglycaemic agent with emerg…
…his cross-sectional proof-of-concept study, 100 patients at the University of Bari (50 FMS per ACR (American College of Rheumatology) 2016 criteri…
…177Lu-PSMA-617 in this disease space. Finally, as patients with prostate cancer are living longer, the review focuses on understanding and mana…